Plantarc Bio Ltd
PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.
Plantarc Bio Ltd (PLNT) - Total Assets
Latest total assets as of June 2025: ILA8.39 Million ILA
Based on the latest financial reports, Plantarc Bio Ltd (PLNT) holds total assets worth ILA8.39 Million ILA as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Plantarc Bio Ltd - Total Assets Trend (2018–2024)
This chart illustrates how Plantarc Bio Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Plantarc Bio Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Plantarc Bio Ltd's total assets of ILA8.39 Million consist of 95.4% current assets and 4.6% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 89.0% |
| Accounts Receivable | ILA602.00K | 5.5% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2018–2024)
This chart illustrates how Plantarc Bio Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Plantarc Bio Ltd's current assets represent 95.4% of total assets in 2024, an increase from 79.2% in 2018.
- Cash Position: Cash and equivalents constituted 89.0% of total assets in 2024, up from 70.4% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 5.5% of total assets.
Plantarc Bio Ltd Competitors by Total Assets
Key competitors of Plantarc Bio Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Plantarc Bio Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Plantarc Bio Ltd generates 0.40x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Plantarc Bio Ltd is currently not profitable relative to its asset base.
Plantarc Bio Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.51 | 9.59 | 4.00 |
| Quick Ratio | 10.51 | 9.59 | 4.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA7.20 Million | ILA 10.07 Million | ILA 1.68 Million |
Plantarc Bio Ltd - Advanced Valuation Insights
This section examines the relationship between Plantarc Bio Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -17.0% |
| Total Assets | ILA10.94 Million |
| Market Capitalization | $19.61K USD |
Valuation Analysis
Below Book Valuation: The market values Plantarc Bio Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Plantarc Bio Ltd's assets decreased by 17.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Plantarc Bio Ltd (2018–2024)
The table below shows the annual total assets of Plantarc Bio Ltd from 2018 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA10.94 Million | -17.04% |
| 2023-12-31 | ILA13.19 Million | -13.41% |
| 2022-12-31 | ILA15.23 Million | -18.63% |
| 2021-12-31 | ILA18.71 Million | +768.04% |
| 2020-12-31 | ILA2.16 Million | -45.15% |
| 2019-12-31 | ILA3.93 Million | +83.78% |
| 2018-12-31 | ILA2.14 Million | -- |